Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma.
Carbon nanotubes are gaining increasing attention due to possible health risks from occupational or environmental exposures. This study tested the hypothesis that inhaled multiwalled carbon nanotubes (MWCNT) would increase airway fibrosis in mice with allergic asthma. Normal and ovalbumin-sensitized mice were exposed to a MWCNT aerosol (100 mg/m(3)) or saline aerosol for 6 hours. Lung injury, inflammation, and fibrosis were examined by histopathology, clinical chemistry, ELISA, or RT-PCR for cytokines/chemokines, growth factors, and collagen at 1 and 14 days after inhalation. Inhaled MWCNT were distributed throughout the lung and found in macrophages by light microscopy, but were also evident in epithelial cells by electron microscopy. Quantitative morphometry showed significant airway fibrosis at 14 days in mice that received a combination of ovalbumin and MWCNT, but not in mice that received ovalbumin or MWCNT only. Ovalbumin-sensitized mice that did not inhale MWCNT had elevated levels IL-13 and transforming growth factor (TGF)-beta1 in lung lavage fluid, but not platelet-derived growth factor (PDGF)-AA. In contrast, unsensitized mice that inhaled MWCNT had elevated PDGF-AA, but not increased levels of TGF-beta1 and IL-13. This suggested that airway fibrosis resulting from combined ovalbumin sensitization and MWCNT inhalation requires PDGF, a potent fibroblast mitogen, and TGF-beta1, which stimulates collagen production. Combined ovalbumin sensitization and MWCNT inhalation also synergistically increased IL-5 mRNA levels, which could further contribute to airway fibrosis. These data indicate that inhaled MWCNT require pre-existing inflammation to cause airway fibrosis. Our findings suggest that individuals with pre-existing allergic inflammation may be susceptible to airway fibrosis from inhaled MWCNT.
Ryman-Rasmussen
Jessica P
JP
North Carolina State University, Box 7633, Raleigh, NC 27695, USA.
Tewksbury
Earl W
EW
Moss
Owen R
OR
Cesta
Mark F
MF
Wong
Brian A
BA
Bonner
James C
JC
D000280:Administration, Inhalation; D000336:Aerosols; D000818:Animals; D001249:Asthma / Q000139:chemically induced / Q000276:immunology / Q000473:pathology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D005355:Fibrosis / Q000139:chemically induced / Q000276:immunology / Q000473:pathology; D006801:Humans; D018793:Interleukin-13 / Q000276:immunology; D008168:Lung / Q000166:cytology / Q000276:immunology / Q000473:pathology*; D008264:Macrophages / Q000166:cytology / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D037742:Nanotubes, Carbon / Q000009:adverse effects* / Q000648:ultrastructure; D010047:Ovalbumin / Q000276:immunology; D010316:Particle Size; D010982:Platelet-Derived Growth Factor / Q000276:immunology; D011897:Random Allocation; D053773:Transforming Growth Factor beta1 / Q000276:immunology
D000336:Aerosols; D018793:Interleukin-13; D037742:Nanotubes, Carbon; D010982:Platelet-Derived Growth Factor; D053773:Transforming Growth Factor beta1; C075278:platelet-derived growth factor A; D010047:Ovalbumin
Am J Respir Crit Care Med. 1997 Apr;155(4):1376-83
9105082
Curr Opin Immunol. 2007 Dec;19(6):676-80
17720466
Am J Respir Cell Mol Biol. 2008 Jul;39(1):45-52
18276795
Clin Immunol. 2006 Nov;121(2):227-35
16979384
Toxicol Sci. 2008 Jan;101(1):179-80; author reply 181-2
17897971
Environ Toxicol. 2007 Aug;22(4):415-21
17607736
Toxicol Appl Pharmacol. 2005 Sep 15;207(3):221-31
16129115
J Allergy Clin Immunol. 2005 Mar;115(3):534-40
15753901
J Clin Invest. 2003 Oct;112(7):1029-36
14523040
Toxicology. 2008 Apr 18;246(2-3):124-31
18289765
Am J Physiol Lung Cell Mol Physiol. 2008 Jan;294(1):L87-97
18024722
Curr Opin Chem Biol. 2005 Dec;9(6):674-9
16233988
Toxicol Sci. 2006 Jul;92(1):5-22
16484287
Cytokine Growth Factor Rev. 2004 Aug;15(4):255-73
15207816
Inhal Toxicol. 2000 Jan-Feb;12(1-2):19-57
10715617
J Clin Invest. 2004 Feb;113(4):551-60
14966564
Nat Nanotechnol. 2008 Jul;3(7):423-8
18654567
J Immunol. 2006 Sep 15;177(6):4141-8
16951379
Science. 1998 Dec 18;282(5397):2258-61
9856949
Respir Res. 2005 Sep 16;6:106
16164761
J Pathol. 2008 Jan;214(2):199-210
18161745
Am J Physiol Lung Cell Mol Physiol. 2005 Nov;289(5):L698-708
15951334
J Toxicol Environ Health A. 2004 Jan 9;67(1):87-107
14668113
Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):109-12
11306943
Toxicol Sci. 2007 Nov;100(1):203-14
17660506
Part Fibre Toxicol. 2006 Nov 29;3:15
17134509
Toxicol Sci. 2004 Jan;77(1):117-25
14514968
Am J Respir Cell Mol Biol. 2007 Sep;37(3):300-8
17496151
Am J Respir Cell Mol Biol. 1990 Nov;3(5):507-11
2223105
Toxicol Sci. 2004 Jan;77(1):126-34
14514958
J Exp Med. 2001 Sep 17;194(6):809-21
11560996